2015-11-03 |
114 |
Stipulation |
invalidity of U.S. Patent Nos. 8,232,250 (“the ’250 patent”), 8,399,413 (“the ’413 patent”), and
8,969,302…8,969,302 (“the ’302 patent) (collectively, the “patents-in-suit”), which, like the ’776 patent, are
…’776 patent shares a common inventor and specification with the
patents-in-suit and each patent is generally… Court:
WHEREAS, U.S. Patent No. 9,155,776 (“the ’776 patent”) issued on October 13, 2015
and…that the patents involve similar subject matter, amending the
pleadings to include the ’776 patent would |
External link to document |
2015-11-10 |
116 |
Patent/Trademark Report to Commissioner |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,232,250; 8,399,413; 8,969,302…2014
31 January 2017
1:14-cv-01171
830 Patent
Defendant
District Court, D. Delaware |
External link to document |
2015-11-20 |
127 |
Notice of Service |
Defendants' Proposed Claim Constructions for U.S. Patent No. 9,155,776 filed by Mylan Inc., Mylan Pharmaceuticals…2014
31 January 2017
1:14-cv-01171
830 Patent
Defendant
District Court, D. Delaware |
External link to document |
2015-12-04 |
130 |
Notice of Service |
Joint Invalidity Contentions Regarding U.S. Patent No. 9,155,776 B2 filed by Momenta Pharmaceuticals Inc.…2014
31 January 2017
1:14-cv-01171
830 Patent
Defendant
District Court, D. Delaware |
External link to document |
2015-12-18 |
139 |
Claim Construction Opening Brief |
CONSTRUCTION OPENING BRIEF Regarding U.S. Patent No. 9,155,776 filed by Momenta Pharmaceuticals Inc., Sandoz…2014
31 January 2017
1:14-cv-01171
830 Patent
Defendant
District Court, D. Delaware |
External link to document |
2015-02-06 |
17 |
Status Report |
of United States Patent
No. 8,232,250 (“the ’250 patent”) and United States Patent No. 8,399,413 (“the…involving the infringement of Teva’s U.S. Patent Nos. 8,232,250 and 8,399,413—namely, Civil
Action Nos.…more claims of the patents-in-suit patent; and (c) whether the claims of the
patents-in-suit are invalid… and Service
These patent infringement suits arise under the Patent Laws of the United States,…“the ’413 patent”).
The ’250 and ’413 patents are listed in FDA publication “Approved Drug Products with |
External link to document |
2016-02-19 |
207 |
|
Joint Invalidity Contentions Regarding U.S. Patent No. 9,155,776 B2 filed by Mylan Inc., Mylan Pharmaceuticals…2014
31 January 2017
1:14-cv-01171
830 Patent
Defendant
District Court, D. Delaware |
External link to document |